Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients / M. Stork ... [et al.]. Neoplasma Vol. 65, no. 4 (2018), s. 585-591
openseadragon
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.
